{
    "clinical_study": {
        "@rank": "90793", 
        "acronym": "Analgesia", 
        "arm_group": [
            {
                "arm_group_label": "oral placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "an Ibuprofen and Acetaminophen Placebo will be added to a Demerol-Vistaril regimen"
            }, 
            {
                "arm_group_label": "Oral Analgesics", 
                "arm_group_type": "Active Comparator", 
                "description": "5 mg/kg ibuprofen + 15 mg/kg acetaminophen will be added to a Demerol-Vistaril regimen"
            }
        ], 
        "brief_summary": {
            "textblock": "All healthcare providers strive continually to improve the outcome of their treatment\n      approaches.  The investigators hypothesize that preventive analgesics administered before a\n      child is sedated with a Demerol-Vistaril regimen will improve the outcome of a sedation."
        }, 
        "brief_title": "Does Preventive Analgesia Improve the Outcome of Demerol-Vistaril Procedural Sedations in Pediatric Dentistry", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Pain", 
        "detailed_description": {
            "textblock": "To increase outcomes for patients receiving dental sedation by providing significant\n      evidence that the new regimen improves the quality of sedation and results in an improved\n      post sedation ability to eat, drink, resume normal activities and require less additional\n      pain medications."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  We intend to enroll 300 children between the ages of 2 - 8 years of all ethnicities\n             for this prospective, placebo controlled, randomized, and double-blind trial. All\n             children that fulfill our general selection criteria for this sedation regimen will\n             be eligible for this study.\n\n        Exclusion Criteria:\n\n          -  Children who do not meet our general selection criteria for this sedation regimen\n             will be ineligible for this study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "8 Years", 
            "minimum_age": "2 Years"
        }, 
        "enrollment": {
            "#text": "300", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 18, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01971853", 
            "org_study_id": "13-1753"
        }, 
        "intervention": [
            {
                "arm_group_label": "oral placebo", 
                "description": "Ibuprofen placebo and Acetaminophen placebo will be added to a Demerol-Vistaril regimen", 
                "intervention_name": "oral placebo", 
                "intervention_type": "Drug", 
                "other_name": "Flavored liquid"
            }, 
            {
                "arm_group_label": "Oral Analgesics", 
                "description": "Ibuprofen at 5.0 mg/kg and Acetaminophen at 15.0 mg/kg will be added to a Demerol-Vistaril regimen", 
                "intervention_name": "Oral Analgesics", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Acetaminophen", 
                "Analgesics", 
                "Meperidine", 
                "Hydroxyzine"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": "Analgesia", 
        "lastchanged_date": "February 27, 2014", 
        "location": {
            "contact": {
                "email": "jeffrey.young@childrenscolorado.org", 
                "last_name": "Jeffrey O Young, DDS", 
                "phone": "720-777-8895"
            }, 
            "facility": {
                "address": {
                    "city": "Aurora", 
                    "country": "United States", 
                    "state": "Colorado", 
                    "zip": "80045"
                }, 
                "name": "Children's Hospital Colorado"
            }, 
            "investigator": {
                "last_name": "Jeffrey O Young, DDS", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Does Preventive Analgesia Improve the Outcome of Demerol-Vistaril Procedural Sedations in Pediatric Dentistry?", 
        "other_outcome": [
            {
                "description": "The differences in time and concentration of nitrous oxide used during treatment will be compared for each study arm.", 
                "measure": "Time of administration of nitrous oxide and oxygen as measured by minutes and percent of nitrous oxide administered", 
                "safety_issue": "No", 
                "time_frame": "From start of treatment (time 0) to 60 minutes"
            }, 
            {
                "description": "A table will be used to determine the complexity of procedures performed by assigning a numerical value to each procedure and determining a total procedure complexity score.", 
                "measure": "Complexity of procedures completed as measured by numerical value using procedure complexity scale in description", 
                "safety_issue": "No", 
                "time_frame": "60 minutes after start of treatment"
            }, 
            {
                "description": "The occurrence of Complications during treatment and recovery will be evaluated. Complications are defined as vomiting, excessive crying, need for supplemental oxygen, and disorientation.", 
                "measure": "Complications during treatment and recovery", 
                "safety_issue": "No", 
                "time_frame": "2 hours in clinic"
            }, 
            {
                "description": "Presence of Post op problems including time and whether problem is constant or intermittent will be as follows: Discomfort when eating/drinking (D), Resumption of normal activity (NA), and Need for additional pain meds (PM)", 
                "measure": "Post operative problems", 
                "safety_issue": "No", 
                "time_frame": "4 hours after patient is discharged"
            }
        ], 
        "overall_contact": {
            "email": "jeffrey.young@childrenscolorado.org", 
            "last_name": "Jeffrey O Young, DDS", 
            "phone": "720-777-8895"
        }, 
        "overall_contact_backup": {
            "email": "ulrich.klein@childrenscolorado.org", 
            "last_name": "Ulrich Klein, DDS", 
            "phone": "720-777-2791"
        }, 
        "overall_official": {
            "affiliation": "University of Colorado, Denver", 
            "last_name": "Jeffrey O Young, DDS", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Institutional Review Board", 
                "United States: Food and Drug Administration"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "A Sedation effectiveness evaluation criteria chart will be utilized to determine a numerical value for the effectiveness as follows:\n1 = Effective/Excellent; 2 = Partially effective/good; 3 = Ineffective/fair; 4 = Aborted/Poor", 
            "measure": "Improved sedation effectiveness based on numerical value for effectiveness as noted in description", 
            "safety_issue": "No", 
            "time_frame": "60 minutes treatment started"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01971853"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "A baseline heart rate will be determined at the beginning of the appointment, and a maximum heart rate will be determined during the appointment.  The differences between baseline and maximum heart rates for each study arm will be compared.", 
            "measure": "Difference in heart rate as measured by numerical delta value", 
            "safety_issue": "No", 
            "time_frame": "From state of treatment (time 0) 60 minutes"
        }, 
        "source": "University of Colorado, Denver", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Colorado, Denver", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}